Survival predictors in unresectable stage III NSCLC treated with induction chemoimmunotherapy: a real-world multicenter study of treatment cycles, response, and maintenance duration

Translational Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles